Wells Fargo’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$2 | – | 7279 |
|
|
2025
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 6965 |
|
|
2024
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 6954 |
|
|
2024
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 6811 |
|
|
2024
Q2 | $3 | Sell |
1
-53
| -98% | -$161 | ﹤0.01% | 6775 |
|
|
2024
Q1 | $168 | Buy |
54
+1
| +2% | +$3 | ﹤0.01% | 6533 |
|
|
2023
Q4 | $145 | Buy |
53
+4
| +8% | +$9 | ﹤0.01% | 6679 |
|
|
2023
Q3 | $105 | Buy |
49
+18
| +58% | +$50 | ﹤0.01% | 6761 |
|
|
2023
Q2 | $115 | Buy |
31
+2
| +7% | +$7 | ﹤0.01% | 6838 |
|
|
2023
Q1 | $94 | Hold |
29
| – | – | ﹤0.01% | 6953 |
|
|
2022
Q4 | $74 | Buy |
29
+1
| +4% | +$4 | ﹤0.01% | 6876 |
|
|
2022
Q3 | $0 | Buy |
28
+1
| +4% | +$7 | ﹤0.01% | 7070 |
|
|
2022
Q2 | $0 | Buy |
27
+2
| +8% | +$16 | ﹤0.01% | 7203 |
|
|
2022
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 7500 |
|
|
2021
Q4 | $0 | Hold |
25
| – | – | ﹤0.01% | 7569 |
|
|
2021
Q3 | $0 | Buy |
25
+4
| +19% | +$78 | ﹤0.01% | 7291 |
|
|
2021
Q2 | $0 | Sell |
21
-1
| -5% | -$24 | ﹤0.01% | 7210 |
|
|
2021
Q1 | $1K | Buy |
22
+15
| +214% | +$455 | ﹤0.01% | 6739 |
|
|
2020
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 6787 |
|
|
2020
Q3 | $0 | Buy |
7
+3
| +75% | +$95 | ﹤0.01% | 6652 |
|
|
2020
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 6598 |
|
|
2020
Q1 | $0 | Buy |
+4
| New | +$155 | ﹤0.01% | 6547 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6576 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6519 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6284 |
|
|
2017
Q2 | – | Sell |
-130
| Closed | -$10K | – | 6351 |
|
|
2017
Q1 | $10K | Buy |
130
+129
| +12,900% | +$8.94K | ﹤0.01% | 5878 |
|
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6361 |
|
|
2016
Q3 | $0 | Sell |
1
-10
| -91% | -$806 | ﹤0.01% | 6270 |
|
|
2016
Q2 | $1K | Buy |
11
+10
| +1,000% | +$920 | ﹤0.01% | 6008 |
|
|
2016
Q1 | $0 | Sell |
1
-468
| -100% | -$46K | ﹤0.01% | 6327 |
|
|
2015
Q4 | $76K | Buy |
469
+241
| +106% | +$44.2K | ﹤0.01% | 5096 |
|
|
2015
Q3 | $51K | Buy |
228
+135
| +145% | +$33.9K | ﹤0.01% | 5259 |
|
|
2015
Q2 | $26K | Buy |
93
+84
| +933% | +$31.2K | ﹤0.01% | 5513 |
|
|
2015
Q1 | $3K | Sell |
9
-10
| -53% | -$5.42K | ﹤0.01% | 5912 |
|
|
2014
Q4 | $10K | Buy |
19
+11
| +138% | +$7.49K | ﹤0.01% | 5629 |
|
|
2014
Q3 | $7K | Sell |
8
-4
| -33% | -$3.5K | ﹤0.01% | 5726 |
|
|
2014
Q2 | $12K | Sell |
12
-38
| -76% | -$36.9K | ﹤0.01% | 5569 |
|
|
2014
Q1 | $53K | Buy |
50
+49
| +4,900% | +$53.1K | ﹤0.01% | 4911 |
|
|
2013
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 5618 |
|
|
2013
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 5528 |
|
|
2013
Q2 | $1K | Buy |
+1
| New | +$877 | ﹤0.01% | 5460 |
|
Other funds holding LSTA
BCM
Wells Fargo's LSTA Position: Q2 2025 in Review
Wells Fargo sold out of Lisata Therapeutics (LSTA) in Q2 2025, closing a stake of 1 share — an estimated $2 sold.
Wells Fargo first reported a position in LSTA in Q2 2013 and held it in 37 quarters. The position peaked at $76K in Q4 2015. 20 funds tracked by Wall St. Rank hold LSTA as of Q2 2025.
- Wells Fargo reported no remaining Lisata Therapeutics position as of Q2 2025 after selling out during the quarter.
- Wells Fargo sold 1 Lisata Therapeutics share in Q2 2025, an estimated $2.
- Wells Fargo first reported a position in Lisata Therapeutics in Q2 2013 and held it in 37 quarters.
- Wells Fargo's Lisata Therapeutics position peaked at $76K in Q4 2015.
- 20 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2025.
Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.